Ibrutinib

Established in 2013, Hefei Home Sunshine Pharmaceutical Technology produces a diverse line spanning prophylactic biological products, vitamins, plant extracts, chiral intermediates, cardiovascular system drugs, and other fine chemicals, selling into North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa. The company highlights internationally approved standards and an experienced R&D staff, along with contract manufacturing (CRO/CMO) capability, willingness to accept buyers' specifications and small orders, and a reputation for quality service.